Muutke küpsiste eelistusi

E-raamat: Urothelial Carcinoma: Methods and Protocols

Edited by , Edited by , Edited by , Edited by
  • Formaat: PDF+DRM
  • Sari: Methods in Molecular Biology 2684
  • Ilmumisaeg: 06-Jul-2023
  • Kirjastus: Springer-Verlag New York Inc.
  • Keel: eng
  • ISBN-13: 9781071632918
Teised raamatud teemal:
  • Formaat - PDF+DRM
  • Hind: 185,24 €*
  • * hind on lõplik, st. muud allahindlused enam ei rakendu
  • Lisa ostukorvi
  • Lisa soovinimekirja
  • See e-raamat on mõeldud ainult isiklikuks kasutamiseks. E-raamatuid ei saa tagastada.
Urothelial Carcinoma: Methods and ProtocolsSuurem pilt
  • Formaat: PDF+DRM
  • Sari: Methods in Molecular Biology 2684
  • Ilmumisaeg: 06-Jul-2023
  • Kirjastus: Springer-Verlag New York Inc.
  • Keel: eng
  • ISBN-13: 9781071632918
Teised raamatud teemal:

DRM piirangud

  • Kopeerimine (copy/paste):

    ei ole lubatud

  • Printimine:

    ei ole lubatud

  • Kasutamine:

    Digitaalõiguste kaitse (DRM)
    Kirjastus on väljastanud selle e-raamatu krüpteeritud kujul, mis tähendab, et selle lugemiseks peate installeerima spetsiaalse tarkvara. Samuti peate looma endale  Adobe ID Rohkem infot siin. E-raamatut saab lugeda 1 kasutaja ning alla laadida kuni 6'de seadmesse (kõik autoriseeritud sama Adobe ID-ga).

    Vajalik tarkvara
    Mobiilsetes seadmetes (telefon või tahvelarvuti) lugemiseks peate installeerima selle tasuta rakenduse: PocketBook Reader (iOS / Android)

    PC või Mac seadmes lugemiseks peate installima Adobe Digital Editionsi (Seeon tasuta rakendus spetsiaalselt e-raamatute lugemiseks. Seda ei tohi segamini ajada Adober Reader'iga, mis tõenäoliselt on juba teie arvutisse installeeritud )

    Seda e-raamatut ei saa lugeda Amazon Kindle's. 

This fully updated volume explores recently improved avenues to study urothelial carcinomas. Beginning with several novel chapters on molecular characterization and urothelial carcinogenesis, the book continues with sections on cellular and animal models, biomarkers, and approaches for targeted therapy. Written for the highly successful Methods in Molecular Biology series, chapters include introductions to their respective topics, lists of the necessary materials and reagents, step-by-step and readily reproducible laboratory protocols, as well as tips on troubleshooting and avoiding known pitfalls. 

Authoritative and practical, Urothelial Carcinoma: Methods and Protocols, Second Edition serves as a valuable resource to further increase our knowledge on urothelial carcinoma and also to aid research on numerous other cancers.
Scoring Systems for Immunohistochemistry in Urothelial Carcinoma.- A
Panel-Based Method for the Reproduction of Distinct Molecular Subtype
Classifications of Muscle-Invasive Urothelial Bladder Cancer.- Analysis of
Mutational Signatures Using the mutSignatures R Library.- A Drug Repurposing
Pipeline Based on Bladder Cancer Integrated Proteotranscriptomics
Signatures.- Characterization of Native COMPASS Complex in Urothelial
Carcinoma Cells by Size Exclusion Chromatography.- Reconstructing
Phylogenetic Relationship in Bladder Cancer: A Methodological
Overview.- Using Sister Chromatid Exchange Assay to Detect Homologous
Recombination Deficiency in Epigenetically Deregulated Urothelial Carcinoma
Cells.- Identification of STAG2 Mutant Bladder Cancers by
Immunohistochemistry.- Genome-Wide CRISPR Screening for the Identification of
Therapy-Resistance-Associated Genes in Urothelial Carcinoma.- Tissue Slice
Culture and Analysis of Tumor-Associated Hyaluronan in Urothelial
Carcinoma.- NGS-Based Tumor-Informed Analysis of Circulating Tumor
DNA.- Considering the Effects of Modern Point-of-Care Urine Biomarker Assays
in Follow-Up of Patients with High-Risk Non-Muscle Invasive Bladder
Cancer.- Simplex Droplet Digital PCR Assays for the Detection of TERT
Promoter Mutations in Urine Samples for the Non-Invasive Diagnosis of
Urothelial Cancer.- Predictive Biomarkers of Response to Neoadjuvant Therapy
in Muscle Invasive Bladder Cancer.- Assessment of PD-L1 Status in Urothelial
Cancer.- Epigenetic Priming and Development of New Combination Therapy
Approaches.- Evaluation of FGFR Alteration Status in Urothelial
Tumors.- Antibody-Drug-Conjugates (ADC): A Novel Treatment Option in
Urothelial Carcinoma.- Intravesical Infusion of Oncolytic Virus CG0070 in the
Treatment of Bladder Cancer.- Analysis of ICAM-1 Expression on Bladder
Carcinoma Cell Lines and Infectivity and Oncolysisby Coxsackie Virus A21.
Lisainfo e-raamatute kohta Lisainfo e-raamatute kohta
Püsilink: https://www.kriso.ee/db/97810716329182e.html
Märksõnad: